All articles by GlobalData Healthcare

  1. Eli Lilly’s, Regeneron’s and Sorrento’s antibody cocktails enticing but improved efficacy over single mAbs for Covid-19 treatment undetermined

    by Manasi Vaidya in New York. Although Eli Lilly’s, Regeneron Pharmaceuticals’ and Sorrento Therapeutics’ monoclonal antibody (mAb) combinations present an…
    Read More…

    27 Jul
  2. Hard hit communities may be better protected for Covid resurgence

    Covid-19 cases have now topped 13 million cases worldwide with several countries, including the US, still seeing a steep rise…
    Read More…

    23 Jul
  3. Fears of a second wave of Covid-19 in Australia after three months of control

    The total number of confirmed cases of COVID-19 continue to rise globally with over 14.5 million cases now reported across…
    Read More…

    22 Jul
  4. The NIH’s innovative approach to streamlining Covid-19 vaccine and drug development: The ACTIV initiative

    The US National Institute of Health (NIH) launched the Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, a public-private partnership…
    Read More…

    22 Jul
  5. As few CMOs are equipped to manufacture cell and gene therapies, viral vector manufacturing and speed must improve, say experts

    As more than 7,000 cell and gene therapies progress through the development pipeline and only 152 CMOs have the capabilities…
    Read More…

    21 Jul
  6. Newly proposed lung cancer screening guidelines expected to double the number of Americans eligible for screening

    Lung cancer, which is responsible for more than 145,000 deaths per year, is the most fatal type of cancer in…
    Read More…

    20 Jul
  7. Truvada likely to be preferred HIV prevention drug despite cabotegravir’s superiority

    On 7 July, GlaxoSmithKline (GSK) released the results for its Phase IIb / III randomised trial for the investigational human…
    Read More…

    20 Jul
  8. Liquidia’s recent announcement to acquire RareGen strengthens its position in the PAH space

    On 29 June, Liquidia Technologies announced its plans to acquire RareGen, which specialises in strategy, investment, and commercialisation of rare…
    Read More…

    20 Jul
  9. Use of stem cells shows promising results in restoring fertility in premature ovarian failure patients

    On 8 July, during this year’s European Society of Human Reproduction and Embryology (ESHRE) congress, encouraging data were presented from…
    Read More…

    20 Jul
  10. Clinigen bets on ALS to revitalise aldesleukin with new orphan drug designation

    On 13 July, UK-based pharmaceutical company Clinigen announced that the FDA had granted orphan drug designation to its anti-cancer drug…
    Read More…

    17 Jul
Close
Close
Close

Go Top